The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex (Q42435280)

31 October 2017

title

The dopaminergic stabilizer pridopidine increases neuronal activity of pyramidal neurons in the prefrontal cortex (English)

1 reference

31 October 2017

1 reference

Benjamin Gronier

1

1 reference

31 October 2017

Susanna Waters

series ordinal

2

1 reference

31 October 2017

Henrik Ponten

series ordinal

3

1 reference

31 October 2017

publication date

7 March 2013

1 reference

Journal of Neural Transmission

31 October 2017

published in

1 reference

31 October 2017

volume

120

1 reference

31 October 2017

issue

9

1 reference

31 October 2017

page(s)

1281-1294

1 reference

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

31 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

The Arc of synaptic memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Dopaminergic control of the striatum for high-level cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Impaired Long-Term Potentiation in the Prefrontal Cortex of Huntington’s Disease Mouse Models: Rescue by D<sub>1</sub> Dopamine Receptor Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D(2) receptor antagonism and fast receptor dissociation properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Effects of amphetamine isomers, methylphenidate and atomoxetine on synaptosomal and synaptic vesicle accumulation and release of dopamine and noradrenaline in vitro in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Enhanced cortical dopamine output and antipsychotic-like effect of raclopride with adjunctive low-dose L-dopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Dopamine D1 and D5 receptors are localized to discrete populations of interneurons in primate prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

In vivo modulation of the firing activity of putative slow- and fast-spiking interneurons in the medial prefrontal cortex by 5-HT3 receptors in 6-hydroxydopamine-induced Parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

In vivo inhibition of neuronal activity in the rat ventromedial prefrontal cortex by midbrain-raphe nuclei: role of 5-HT1A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Bursting of prefrontal cortex neurons in awake rats is regulated by metabotropic glutamate 5 (mGlu5) receptors: rate-dependent influence and interaction with NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

NMDA antagonist and antipsychotic actions in cortico-subcortical circuits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Synaptic activity-responsive element in the Arc/Arg3.1 promoter essential for synapse-to-nucleus signaling in activated neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

The dopamine stabilizers (S)-(-)-(3-methanesulfonyl-phenyl)-1-propyl-piperidine [(-)-OSU6162] and 4-(3-methanesulfonylphenyl)-1-propyl-piperidine (ACR16) show high in vivo D2 receptor occupancy, antipsychotic-like efficacy, and low potential for mot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Synthesis and evaluation of a set of 4-phenylpiperidines and 4-phenylpiperazines as D2 receptor ligands and the discovery of the dopaminergic stabilizer 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine (huntexil, pridopidine, ACR16).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

In vivo pharmacology of the dopaminergic stabilizer pridopidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

The dopaminergic stabilizer pridopidine decreases expression of L-DOPA-induced locomotor sensitisation in the rat unilateral 6-OHDA model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Parvalbumin-positive basket interneurons in monkey and rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

The principal features and mechanisms of dopamine modulation in the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Dopamine modulates an mGluR5-mediated depolarization underlying prefrontal persistent activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

What the rodent prefrontal cortex can teach us about attention-deficit/hyperactivity disorder: the critical role of early developmental events on prefrontal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Dopaminergic signaling and striatal neurodegeneration in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Dopamine modulates temporal dynamics of feedforward inhibition in rat prefrontal cortex in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Dopamine modulation of prefrontal cortical interneurons changes during adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

α2-Adrenoceptor regulates the spontaneous and the GABA/glutamate modulated firing activity of the rat medial prefrontal cortex pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-013-1002-4

Intrinsic circuit organization of the major layers and sublayers of the dorsolateral prefrontal cortex in the rhesus monkey

21 January 2018

1 reference

12 December 2020

Intracortical 6-hydroxydopamine induced an asymmetrical behavioral response in the rat

1 reference

12 December 2020

Electrophysiological effects of selective D1 and D2 dopamine receptor agonists in the medial prefrontal cortex of young and aged Fischer 344 rats.

1 reference

12 December 2020

R( )-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum

1 reference

12 December 2020

Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs

1 reference

12 December 2020

Effects of sigma receptor ligands on the extracellular concentration of dopamine in the striatum and prefrontal cortex of the rat

1 reference

12 December 2020

In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: Involvement of dopamine D1 and alpha 2 adrenergic receptors

1 reference

12 December 2020

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system

1 reference

12 December 2020

Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat

1 reference

12 December 2020

Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study

1 reference

12 December 2020

The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor

1 reference

12 December 2020

Age-dependent effects of methylphenidate in the prefrontal cortex: evidence from electrophysiological and Arc gene expression measurements

1 reference

12 December 2020

Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.

1 reference

12 December 2020

10.1007/S00702-013-1002-4

Identifiers

DOI

1 reference

Dimensions Publication ID

31 October 2017

1031863643

0 references

1 reference